Companies / Consumer Discretionary
TPR
Tapestry, Inc.
Apparel, Accessories & Luxury Goods
Apparel, Accessories & Luxury GoodsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health80
Growth60
Profitability80
Cash generation95
Balance sheet67
Dilution control99
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-26)11.1%Revenue growth (FY)14.2%Revenue CAGR (3y)6.3%Gross margin77.8%Operating margin23.9%Net margin19.1%Free cash flow margin22.6%R&D / revenue—Stock comp / revenue1.3%Net debt / operating cash flow0.71xCurrent ratio1.75Diluted share count change-5.5%
| Fiscal year ending | FY 2022-07 | FY 2023-07 | FY 2024-06 | FY 2025-06 | FY 2026-06 |
|---|---|---|---|---|---|
| Revenue | $6.7B | $6.7B | $6.7B | $7.0B | $8.0B |
| Gross profit | $4.7B | $4.7B | $4.9B | $5.3B | $6.2B |
| Operating income | $1.2B | $1.2B | $1.1B | $415M | $1.9B |
| Net income | $856M | $936M | $816M | $183M | $1.5B |
| Operating cash flow | $853M | $975M | $1.3B | $1.2B | $2.0B |
| Capital expenditure | $94M | $184M | $109M | $123M | $166M |
| Free cash flow | $759M | $791M | $1.1B | $1.1B | $1.8B |
| Stock-based comp | $72M | $79M | $86M | $87M | $104M |
| Buybacks | $1.6B | $704M | $0 | $1.7B | $1.6B |
| Dividends | $264M | $283M | $321M | $299M | $326M |
| Cash | $790M | $726M | $6.1B | $1.1B | $975M |
| Total debt | $1.7B | $1.7B | $7.2B | $2.4B | $2.4B |
| Equity | $2.3B | $2.3B | $2.9B | $858M | $692M |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.